title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Friday,20220506T160650,https://www.benzinga.com/markets/options/22/05/27050916/52-weeks-high-and-low-article,AKTX,0.005467,Neutral,0.007395
Akari Therapeutics  ( NASDAQ:AKTX )  Receives New Coverage from Analysts at StockNews.com,20230609T055847,https://www.defenseworld.net/2023/06/09/akari-therapeutics-nasdaqaktx-receives-new-coverage-from-analysts-at-stocknews-com.html,AKTX,0.891977,Bullish,0.446063
"Akari Therapeutics  ( NASDAQ:AKTX ) , InMed Pharmaceuticals  ( NASDAQ:INM )  - S&P 500 Rises 1%, InMed Pharmaceuticals Shares Spike Higher",20220912T184449,https://www.benzinga.com/news/earnings/22/09/28835570/s-p-500-rises-1-inmed-pharmaceuticals-shares-spike-higher,AKTX,0.154455,Neutral,-0.111019
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday,20220801T092759,https://www.benzinga.com/news/22/08/28283022/this-communication-services-stock-jumped-149-here-are-90-biggest-movers-from-friday,AKTX,0.064914,Neutral,0.086507
"The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation",20220517T130455,https://www.benzinga.com/general/biotech/22/05/27249090/the-daily-biotech-pulse-pfizer-biontechs-covid-19-booster-for-5-11-year-kids-soon-ultragenyx-in-l,AKTX,0.08978,Neutral,-0.000643
